Dechra Pharmaceuticals PLC (LSE:DPH) - Share price - Overview

Stock Report

Dechra Pharmaceuticals PLC DPH

Last Price
GBX2,948.00

Day Change
-28.00|-0.94%

As of 18/07/2018
17:48:15 BST | GBX
Minimum 15 Minutes Delay.

Last Close2,976.00p
Day Range2,924.00 - 2,998.00
Mkt Cap3.05Bil
52-Wk Range1,689.00 - 3,032.00
Yield %0.65
ISINGB0009633180
Volume259,244
P/E93.42
P/S0.08
P/CF0.36

Share Price

Total Returns 17/07/2018

 Chg (%)  
More ...
Dechra Pharmaceuticals PLC8.93 
FTSE 100 TR GBP0.03
 
Financials
201520162017
More ...
Income Statement
Turnover203.48247.56359.28
Operating Profit26.4826.6436.68
Net Profit19.4612.5126.11
Reported EPS21.9913.9027.93
Balance Sheet
Current Assets108.62162.39184.98
Non Current Assets184.90393.44453.09
Total Assets293.53555.83638.07
Current Liabilities44.1165.9866.41
Total Liabilities99.04279.22335.43
Total Equity194.49276.61302.64
Cash Flow
Operating Cash Flow45.6555.0689.43
Net Change in Cash21.51-5.1521.74

Regulatory News

Director Dealings
TradedActionNotifierPriceAmountValue
More ...
02/03/2018Exercise of OptionMr. Ian David Page614.001,4658,995.00
27/02/2018PurchaseDr. Lawson Macartney34.005,880199,920.00
26/02/2018Exercise of OptionMr. Richard John Cotton0.0021,0330.00
19/09/2017Sale of OptionMr. Ian David Page2,023.9254,9101,111,333.00

Company Profile

Dechra Pharmaceuticals PLC is engaged in veterinary pharmaceuticals and related products business. The company is engaged in development, manufacture and marketing of products for veterinarians.

Sector

Drug Manufacturers - Major

Index

FTSE 250 ,FTSE 350 ,FTSE All Share

Next Event 03/09/2018

Final Results
Ratios
Comp
More ...
PER (E)60.53
Div Yld (E)0.81
PEG (E)0.00
ROCE5.00
Op Mrgn0.10
EPS Grwth0.41
Dividends
PreviousLatest
More ...
Record Date27/10/1709/03/18
Ex-Div26/10/1708/03/18
Paid17/11/1706/04/18
Amnt15.337.33
Directors
More ...
Executive Director, Chief ExecutiveMr. Ian David Page
Non-Executive DirectorDr. Lawson Macartney
Executive Director, Chief Financial OfficerMr. Richard John Cotton
Executive DirectorMr. Anthony Griffin
Non-Executive Director, ChairmanMr. William Anthony Rice
Non-Executive DirectorMs. Ishbel Jean Stewart Macpherson
Non-Executive DirectorJulian Heslop
AJ Bell includes AJ Bell Holdings Limited and its wholly owned subsidiaries. AJ Bell Management Limited and AJ Bell Securities Limited are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2018 Morningstar. All rights reserved.